Skip to main navigation Skip to search Skip to main content

Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals

  • Manuel J. Quiñones
  • , Miguel Hernandez-Pampaloni
  • , Heinrich Schelbert
  • , Isabel Bulnes-Enriquez
  • , Xochitl Jimenez
  • , Gustavo Hernandez
  • , Roxana De La Rosa
  • , Yun Chon
  • , Hulying Yang
  • , Susanne B. Nicholas
  • , Tamara Modilevsky
  • , Katherine Yu
  • , Katja Van Herle
  • , Lawrence W. Castellani
  • , Robert Elashoff
  • , Willa A. Hsueh

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Insulin resistance is a metabolic spectrum that progresses from hyperinsulinemia to the metabolic syndrome, impaired glucose tolerance, and finally type 2 diabetes mellitus. It is unclear when vascular abnormalities begin in this spectrum of metabolic effects. Objective: To evaluate the association of insulin resistance with the presence and reversibility of coronary vasomotor abnormalities in young adults at low cardiovascular risk. Design: Cross-sectional study followed by prospective, open-label treatment study. Setting: University hospital. Patients: 50 insulin-resistant and 22 insulin-sensitive, age-matched Mexican-American participants without glucose intolerance or traditional risk factors for or evidence of coronary artery disease. Intervention: 3 months of thiazolidinedione therapy for 25 insulin-resistant patients. Measurements: Glucose infusion rate in response to insulin infusion was used to define insulin resistance (glucose infusion rate ≤ 4.00 mg/kg of body weight per minute [range, 0.90 to 3.96 mg/kg per minute]) and insulin sensitivity (glucose infusion rate ≥ 7.50 mg/kg per minute [range, 7.52 to 13.92 mg/kg per minute]). Myocardial blood flow was measured by using positron emission tomography at rest, during cold pressor test (largely endothelium-dependent), and after dipyridamole administration (largely vascular smooth muscle-dependent). Results: Myocardial blood flow responses to dipyridamole were similar in the Insulin-sensitive and insulin-resistant groups. However, myocardial blood flow response to cold pressor test increased by 47.6% from resting values in insulin-sensitive patients and by 14.4% in insulin-resistant patients. During thiazolidinedione therapy in a subgroup of insulin-resistant patients, insulin sensitivity improved, fasting plasma insulin levels decreased, and myocardial blood flow responses to cold pressor test normalized. Limitations: The study was not randomized, and it included only 1 ethnic group. Conclusions: Insulin-resistant patients who do not have hypercholesterolemia or hypertension and do not smoke manifest coronary vasomotor abnormalities. Insulin-sensitizing thiazolidinedione therapy normalized these abnormalities. These results suggest an association between insulin resistance and abnormal coronary vasomotor function, a relationship that requires confirmation in larger studies.

Original languageEnglish
Pages (from-to)700-708+I32
JournalAnnals of Internal Medicine
Volume140
Issue number9
DOIs
StatePublished - May 4 2004

Fingerprint

Dive into the research topics of 'Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals'. Together they form a unique fingerprint.

Cite this